Galectin-9 controls CD40 signaling through a Tim-3 independent mechanism and redirects the cytokine profile of pathogenic T cells in autoimmunity

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Vaitaitis, Gisela M ^a   Wagner, David H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CYTOKINE; ECALECTIN; HYBRID PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GLYCOBIOLOGY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE;

EID: 84862007833     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038708     Document Type: Article

References (43)

1. Law CL, Grewal IS, (2009) Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges. Adv Exp Med Biol 647: 8-36.
2. Loskog AS, Eliopoulos AG, (2009) The Janus faces of CD40 in cancer. Semin Immunol 21: 301-307.
3. Vonderheide RH, (2007) Prospect of targeting the CD40 pathway for cancer therapy. Clin Cancer Res 13: 1083-1088.
4. Margolles-Clark E, Umland O, Kenyon NS, Ricordi C, Buchwald P, (2009) Small-molecule costimulatory blockade: organic dye inhibitors of the CD40-CD154 interaction. J Mol Med 87: 1133-1143.
5. Nanji SA, Hancock WW, Luo B, Schur CD, Pawlick RL, et al. (2006) Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Diabetes 55: 27-33.
6. Wyzgol A, Muller N, Fick A, Munkel S, Grigoleit GU, et al. (2009) Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand. J Immunol 183: 1851-1861.
7. Suo Z, Wu M, Ameenuddin S, Anderson HE, Zoloty JE, et al. (2002) Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J Neurochem 80: 655-666.
8. van Kooten C, Banchereau J, (2000) CD40-CD40 ligand. J Leukoc Biol 67: 2-17.
9. Poggi M, Jager J, Paulmyer-Lacroix O, Peiretti F, Gremeaux T, et al. (2009) The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes. Diabetologia 52: 1152-1163.
10. Wagner DH Jr, (2009) The co-evolution of our understanding of CD40 and inflammation. Diabetologia 52: 997-999.
11. Wagner DH Jr, Newell E, Sanderson RJ, Freed JH, Newell MK, (1999) Increased expression of CD40 on thymocytes and peripheral T cells in autoimmunity: a mechanism for acquiring changes in the peripheral T cell receptor repertoire. Int J Mol Med 4: 231-242.
12. Wagner DH Jr, Vaitaitis G, Sanderson R, Poulin M, Dobbs C, et al. (2002) Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc Natl Acad Sci U S A 99: 3782-3787.
13. Vaitaitis GM, Wagner DH Jr, (2008) High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity. PLoS One 3: e2076.
14. Waid DM, Vaitaitis GM, Wagner DH Jr, (2004) Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus. Eur J Immunol 34: 1488-1497.
15. Waid DM, Wagner RJ, Putnam A, Vaitaitis GM, Pennock ND, et al. (2007) A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes. Clin Immunol 124: 138-148.
16. Waid DM, Vaitaitis GM, Pennock ND, Wagner DH Jr, (2008) Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes. J Leukoc Biol 84: 431-439.
17. Vaitaitis GM, Wagner DH Jr, (2010) CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity. Mol Immunol 47: 2303-2313.
18. Balasa B, Krahl T, Patstone G, Lee J, Tisch R, et al. (1997) CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J Immunol 159: 4620-4627.
19. Marth JD, Grewal PK, (2008) Mammalian glycosylation in immunity. Nat Rev Immunol 8: 874-887.
20. Grigorian A, Lee SU, Tian W, Chen IJ, Gao G, et al. (2007) Control of T Cell-mediated autoimmunity by metabolite flux to N-glycan biosynthesis. J Biol Chem 282: 20027-20035.
21. Morgan R, Gao G, Pawling J, Dennis JW, Demetriou M, et al. (2004) N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells. J Immunol 173: 7200-7208.
22. Demetriou M, Granovsky M, Quaggin S, Dennis JW, (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409: 733-739.
23. Lee SU, Grigorian A, Pawling J, Chen IJ, Gao G, et al. (2007) N-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration. J Biol Chem 282: 33725-33734.
24. Klyosov AA, Witczak ZJ, Platt D, (2008) Galectins. Hoboken, New Jersey John Wiley & Sons, Inc.
25. Yang RY, Hsu DK, Liu FT, (1996) Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A 93: 6737-6742.
26. Wang J, Lu ZH, Gabius HJ, Rohowsky-Kochan C, Ledeen RW, et al. (2009) Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J Immunol 182: 4036-4045.
27. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, et al. (2005) The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6: 1245-1252.
28. Chou FC, Shieh SJ, Sytwu HK, (2009) Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur J Immunol 39: 2403-2411.
29. Su EW, Bi S, Kane LP, (2010) Galectin-9 regulates T helper cell function independently of Tim-3. Glycobiology 21: 1258-1265.
30. Hiller S, Garces RG, Malia TJ, Orekhov VY, Colombini M, et al. (2008) Solution structure of the integral human membrane protein VDAC-1 in detergent micelles. Science 321: 1206-1210.
31. Hoxie JA, Matthews DM, Callahan KJ, Cassel DL, Cooper RA, (1986) Transient modulation and internalization of T4 antigen induced by phorbol esters. J Immunol 137: 1194-1201.
32. Munroe ME, Bishop GA, (2007) A costimulatory function for T cell CD40. J Immunol 178: 671-682.
33. Baker RL, Wagner DH Jr, Haskins K, (2008) CD40 on NOD CD4 T cells contributes to their activation and pathogenicity. J Autoimmun 31: 385-392.
34. Hatzifoti C, Heath AW, (2007) CD40-mediated enhancement of immune responses against three forms of influenza vaccine. Immunology 122: 98-106.
35. Barr T, Carlring J, Hatzifoti C, Heath AW, (2006) Antibodies against cell surface antigens as very potent immunological adjuvants. Vaccine 24 (Suppl 2): S2-20-21.
36. Carlring J, Barr TA, McCormick AL, Heath AW, (2004) CD40 antibody as an adjuvant induces enhanced T cell responses. Vaccine 22: 3323-3328.
37. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY, (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6: 1142-1151.
38. Wagner DH Jr, (2007) Re-shaping the T cell repertoire: TCR editing and TCR revision for good and for bad. Clin Immunol 123: 1-6.
39. Niwa H, Satoh T, Matsushima Y, Hosoya K, Saeki K, et al. (2009) Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation. Clin Immunol 132: 184-194.
40. Seki M, Oomizu S, Sakata KM, Sakata A, Arikawa T, et al. (2008) Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127: 78-88.
41. Heath AW, Wu WW, Howard MC, (1994) Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur J Immunol 24: 1828-1834.
42. Rolink A, Melchers F, Andersson J, (1996) The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 5: 319-330.
43. Desbarats J, Newell MK, (2000) Fas engagement accelerates liver regeneration after partial hepatectomy. Nat Med 6: 920-923.